Alexander Buchner
Overview
Explore the profile of Alexander Buchner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
192
Citations
1951
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Marcon J, Bischoff R, Rattenhuber K, Chaloupka M, Askari D, Jokisch J, et al.
J Clin Med
. 2025 Jan;
13(24.
PMID: 39768429
Higher intraoperative opioid doses may be associated with worse long-term oncological outcomes after radical prostatectomy (RP) for prostate cancer. We aimed to evaluate the impact of higher doses of intraoperative...
2.
Kempin S, Buchner A, Brose S, Schmidt-Hegemann N, May M, Wolff I, et al.
Cancers (Basel)
. 2025 Jan;
16(24.
PMID: 39766184
: Prostate cancer (PC) and its treatment are often associated with side effects such as fatigue, muscle loss, and diminished quality of life (QoL). Physical exercise, particularly resistance training (RT)...
3.
Tamalunas A, Paktiaval R, Lenau P, Stadelmeier L, Buchner A, Kolben T, et al.
Patient Prefer Adherence
. 2024 Dec;
18:2507-2518.
PMID: 39678359
Purpose: Lower urinary tract symptoms (LUTS) consist of voiding and storage symptoms. While the therapeutic efficacy of current LUTS medications is limited, and with more than 20% of patients suffering...
4.
Eismann L, Rodler S, Buchner A, Strittmatter F, Alghamdi A, Lennartz S, et al.
Urol Int
. 2024 Dec;
:1-7.
PMID: 39647473
Introduction: Ureteral access sheaths (UASs) are widely used in the endoscopic treatment of urolithiasis. In modern medicine, radiation exposure from diagnostics and therapy is increasing; however, the impact of UAS...
5.
Westhofen T, Buchner A, Lennartz S, Rodler S, Eismann L, Aydogdu C, et al.
World J Urol
. 2024 Oct;
42(1):585.
PMID: 39427278
Objective: To investigate the prognostic value of baseline health-related quality of life (HRQOL) for patients with intermediate-risk localized prostate cancer (IR-PCa) undergoing radical prostatectomy (RP). Methods: 4780 patients with IR-PCa...
6.
Marcon J, Yefsah F, Schulz G, Weinhold P, Rodler S, Eismann L, et al.
Cancers (Basel)
. 2024 Oct;
16(19).
PMID: 39410030
Background: An increased intraoperative opioid dose seems to lead to worse outcomes in several types of cancer. We assessed the effect of intraoperatively administered opioids as well as the type...
7.
Ma J, Rogowski P, Trapp C, Manapov F, Xu B, Buchner A, et al.
Clin Transl Radiat Oncol
. 2024 Oct;
49:100868.
PMID: 39381629
Purpose: This study aims to address therapy-related toxicities and quality of life in prostate cancer patients undergoing transperineal ultrasound (TPUS) guided radiotherapy (RT). Methods: Acute and late gastrointestinal (GI) and...
8.
Sheikh G, Trapp C, Schmidt-Hegemann N, Buchner A, Stief C, Unterrainer M, et al.
EJNMMI Rep
. 2024 Aug;
8(1):25.
PMID: 39155339
Objective: Bone metastases are very common in advanced prostate cancer and can sensitively be detected utilizing PSMA-PET/CT. Therefore, our goal was to evaluate the suitability of PSMA-PET/CT-guided metastasis-directed external beam...
9.
Westhofen T, Frank K, Buchner A, Becker A, Eismann L, Rodler S, et al.
World J Urol
. 2024 Jul;
42(1):432.
PMID: 39037579
Objectives: While the impact of treatment with 5-alpha Reductase Inhibitors (5-ARI) on the risk of cancer-related mortality in men with prostate cancer (PC) has been extensively studied, little is known...
10.
Pachyn E, Aumiller M, Freymuller C, Linek M, Volgger V, Buchner A, et al.
Sci Rep
. 2024 Jun;
14(1):13979.
PMID: 38886457
Hyperspectral imaging (HSI) is a new emerging modality useful for the noncontact assessment of free flap perfusion. This measurement technique relies on the optical properties within the tissue. Since the...